Cargando…
Safety, tolerability, and biomarkers of the treatment of mice with aerosolized Toll-like receptor ligands
We have previously discovered a synergistically therapeutic combination of two Toll-like receptor ligands, an oligodeoxynucleotide (ODN) and Pam2CSK4. Aerosolization of these ligands stimulates innate immunity within the lungs to prevent pneumonia from bacterial and viral pathogens. Here we examined...
Autores principales: | Alfaro, Victoria Y., Goldblatt, David L., Valverde, Gabriella R., Munsell, Mark F., Quinton, Lee J., Walker, Adam K., Dantzer, Robert, Varadhachary, Atul, Scott, Brenton L., Evans, Scott E., Tuvim, Michael J., Dickey, Burton F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3915096/ https://www.ncbi.nlm.nih.gov/pubmed/24567720 http://dx.doi.org/10.3389/fphar.2014.00008 |
Ejemplares similares
-
Epithelial immunomodulation by aerosolized Toll-like receptor agonists prevents allergic inflammation in airway mucosa in mice
por: Goldblatt, David L., et al.
Publicado: (2022) -
Airway Epithelial Innate Immunity
por: Johnston, Sebastian L., et al.
Publicado: (2021) -
Synergistic TLR2/6 and TLR9 Activation Protects Mice against Lethal Influenza Pneumonia
por: Tuvim, Michael J., et al.
Publicado: (2012) -
Immune Modulation to Improve Survival of Viral Pneumonia in Mice
por: Wali, Shradha, et al.
Publicado: (2020) -
Augmented Lung Inflammation Protects against Influenza A Pneumonia
por: Tuvim, Michael J., et al.
Publicado: (2009)